# National HealthCare Corporation (NHC) Stock Analysis: Discovering Growth in Healthcare with a 25.7% Revenue Surge

- Link: https://www.directorstalkinterviews.com/national-healthcare-corporation-nhc-stock-analysis-discovering-growth-in-healthcare-with-a-25-7-revenue-surge/4121206552
- Published: 2025-07-08T10:39:43+01:00
- Author: Madison Wilson

National HealthCare Corporation (NYSE: NHC) stands out in the healthcare sector,
not only for its comprehensive range of services but also for its remarkable revenue
growth. With a substantial 25.7% increase in revenue, NHC is capturing the attention
of investors looking for promising opportunities in medical care facilities.

As a key player in the U.S. healthcare industry, NHC operates across multiple segments,
including skilled nursing facilities, assisted and independent living facilities,
homecare and hospice services. Headquartered in Murfreesboro, Tennessee, the company
has been providing essential healthcare services since its founding in 1971.

Currently, NHC is trading at $104.23, with a 52-week range of $89.91 to $137.13.
While the stock has experienced a slight dip of 0.04%, its long-term prospects remain
strong, especially given the company’s robust financial performance and strategic
positioning in an ever-growing industry.

Despite not having a defined price-to-earnings (P/E) ratio or PEG ratio available,
NHC’s earnings per share (EPS) of 6.91 and a return on equity of 11.18% reflect 
its ability to generate profits and deliver solid returns to shareholders. The company’s
free cash flow of approximately $85.8 million further underscores its financial 
health and potential for future growth.

Investors seeking income can also appreciate NHC’s dividend yield of 2.39%, supported
by a conservative payout ratio of 35.31%. This indicates that the company retains
a significant portion of its earnings, which can be reinvested into the business
for expansion and innovation.

From a technical perspective, NHC’s 50-day moving average stands at 102.99, while
its 200-day moving average is 107.40. The relative strength index (RSI) at 80.35
suggests that the stock is currently overbought, which might warrant a cautious 
approach for short-term investors. However, the company’s long-term fundamentals
remain solid, with a positive MACD of 1.24, although slightly below the signal line
of 1.44.

One intriguing aspect of NHC is the absence of analyst ratings, leaving the stock
in a relatively uncharted territory. This scenario presents a unique opportunity
for investors who prefer to rely on their own research and insights rather than 
consensus opinions.

NHC’s diverse service offerings, ranging from rehabilitative services to memory 
care units and hospice agencies, position it well to capitalize on the increasing
demand for healthcare services, particularly as the population ages. Moreover, its
strategic focus on both inpatient and homecare services offers a balanced approach
to addressing varied patient needs.

For investors with a long-term horizon, National HealthCare Corporation presents
a compelling case. Its strong revenue growth, consistent dividend payments, and 
strategic market positioning make it a noteworthy consideration in the healthcare
sector. As the company continues to expand its services and adapt to evolving healthcare
needs, it holds the potential to deliver substantial value to shareholders.

Share on: